MedTech Outlook Magazine recognized Biologica Technologies as one of the Top 10 MedTech Startups in 2019.
Four things to know:
1. The annual MedTech list honors companies that tackle surgical challenges in orthopedics.
2. Biologica's main product, ProteiOS growth factor, is a soluble protein compound derived from the endosteum of allograft bone.
3. ProteiOS consists of a collection of growth factors, oxygenating peptides, collagen deposition peptides and cellular attachment peptides.
4. The product was initially launched for the orthopedic and neurosurgery markets.